Literature DB >> 17488297

Long-term T cell memory to human leucocyte antigen-A2 supertype epitopes in humans vaccinated against smallpox.

N D Ostrout1, M M McHugh, D J Tisch, A M Moormann, V Brusic, J W Kazura.   

Abstract

Identification of human leucocyte antigen (HLA) class I-restricted T cell epitopes is important to develop methods to track the evolution of T cell memory to new generation smallpox vaccines and allow comparison to older vaccinia virus preparations known to induce protection against smallpox. We evaluated the relative predictive values of four computational algorithms to identify candidate 9-mer HLA-A2 supertype epitopes that were confirmed to stimulate preferentially T cell interferon (IFN)-gamma responses by subjects last vaccinated with Dryvax 27-54 years previously. Six peptides encoded by I4L, G1L, A8R, I8R, D12L and H3L open reading frames that were identical for Vaccinia (Copenhagen), Variola major (Bangledesh 1975) and modified vaccinia Ankara strain preferentially stimulated IFN-gamma responses by healthy HLA-A2 supertype adults last given Dryvax 27-49 years earlier relative to remotely vaccinated non-HLA-A2 supertype and unvaccinated HLA-A2 supertype adults. Combining results from at least two computational algorithms that use different strategies to predict peptide binding to HLA-A2 supertype molecules was optimal for selection of candidate peptides that were confirmed to be epitopes by recall of T cell IFN-gamma responses. These data will facilitate evaluation of the immunogenicity of replication incompetent smallpox vaccines such as modified vaccinia Ankara and contribute to knowledge of poxvirus epitopes that are associated with long-lived T cell memory.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17488297      PMCID: PMC1941954          DOI: 10.1111/j.1365-2249.2007.03401.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  31 in total

1.  Cutting edge: long-term B cell memory in humans after smallpox vaccination.

Authors:  Shane Crotty; Phil Felgner; Huw Davies; John Glidewell; Luis Villarreal; Rafi Ahmed
Journal:  J Immunol       Date:  2003-11-15       Impact factor: 5.422

Review 2.  Regulation of vaccinia virus transcription.

Authors:  B Moss
Journal:  Annu Rev Biochem       Date:  1990       Impact factor: 23.643

Review 3.  Practical, biochemical and evolutionary implications of the discovery of HLA class I supermotifs.

Authors:  J Sidney; H M Grey; R T Kubo; A Sette
Journal:  Immunol Today       Date:  1996-06

4.  Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains.

Authors:  K C Parker; M A Bednarek; J E Coligan
Journal:  J Immunol       Date:  1994-01-01       Impact factor: 5.422

5.  Primary induction of human CD8+ cytotoxic T lymphocytes and interferon-gamma-producing T cells after smallpox vaccination.

Authors:  Francis A Ennis; John Cruz; Walter E Demkowicz; Alan L Rothman; David J McClain
Journal:  J Infect Dis       Date:  2002-05-17       Impact factor: 5.226

6.  Human cytotoxic T-cell memory: long-lived responses to vaccinia virus.

Authors:  W E Demkowicz; R A Littaua; J Wang; F A Ennis
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

7.  A successful eradication campaign. Global eradication of smallpox.

Authors:  F Fenner
Journal:  Rev Infect Dis       Date:  1982 Sep-Oct

8.  Protection against lethal vaccinia virus challenge in HLA-A2 transgenic mice by immunization with a single CD8+ T-cell peptide epitope of vaccinia and variola viruses.

Authors:  James T Snyder; Igor M Belyakov; Amiran Dzutsev; François Lemonnier; Jay A Berzofsky
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

Review 9.  Smallpox, vaccination and adverse reactions to smallpox vaccine.

Authors:  Andreas Wollenberg; Renata Engler
Journal:  Curr Opin Allergy Clin Immunol       Date:  2004-08

10.  Temporal regulation of influenza hemagglutinin expression in vaccinia virus recombinants and effects on the immune response.

Authors:  B E Coupar; M E Andrew; G W Both; D B Boyle
Journal:  Eur J Immunol       Date:  1986-12       Impact factor: 5.532

View more
  8 in total

1.  Vaccinia virus-specific CD8(+) T-cell responses target a group of epitopes without a strong immunodominance hierarchy in humans.

Authors:  Masanori Terajima; Laura Orphin; Anita M Leporati; Pamela Pazoles; John Cruz; Alan L Rothman; Francis A Ennis
Journal:  Hum Immunol       Date:  2008-10-26       Impact factor: 2.850

Review 2.  Uncovering the interplay between CD8, CD4 and antibody responses to complex pathogens.

Authors:  Magdalini Moutaftsi; David C Tscharke; Kerrie Vaughan; David M Koelle; Lawrence Stern; Mauricio Calvo-Calle; Francis Ennis; Masanori Terajima; Gerd Sutter; Shane Crotty; Ingo Drexler; Genoveffa Franchini; Jon W Yewdell; Steven R Head; Janice Blum; Bjoern Peters; Alex Sette
Journal:  Future Microbiol       Date:  2010-02       Impact factor: 3.165

3.  New p35 (H3L) Epitope Involved in Vaccinia Virus Neutralization and Its Deimmunization.

Authors:  Yana Khlusevich; Andrey Matveev; Lyudmila Emelyanova; Elena Goncharova; Natalia Golosova; Ivan Pereverzev; Nina Tikunova
Journal:  Viruses       Date:  2022-06-05       Impact factor: 5.818

4.  MHC-I-restricted epitopes conserved among variola and other related orthopoxviruses are recognized by T cells 30 years after vaccination.

Authors:  S T Tang; M Wang; K Lamberth; M Harndahl; M H Dziegiel; M H Claesson; S Buus; O Lund
Journal:  Arch Virol       Date:  2008-09-12       Impact factor: 2.574

5.  Discovery of naturally processed and HLA-presented class I peptides from vaccinia virus infection using mass spectrometry for vaccine development.

Authors:  Kenneth L Johnson; Inna G Ovsyannikova; Christopher J Mason; H Robert Bergen; Gregory A Poland
Journal:  Vaccine       Date:  2009-10-12       Impact factor: 3.641

6.  In silico-accelerated identification of conserved and immunogenic variola/vaccinia T-cell epitopes.

Authors:  Leonard Moise; Julie A McMurry; Soren Buus; Sharon Frey; William D Martin; Anne S De Groot
Journal:  Vaccine       Date:  2009-06-24       Impact factor: 3.641

7.  HLA class I supertypes: a revised and updated classification.

Authors:  John Sidney; Bjoern Peters; Nicole Frahm; Christian Brander; Alessandro Sette
Journal:  BMC Immunol       Date:  2008-01-22       Impact factor: 3.615

8.  Evaluating immunogenicity of pathogen-derived T-cell epitopes to design a peptide-based smallpox vaccine.

Authors:  Huy Quang Quach; Inna G Ovsyannikova; Gregory A Poland; Richard B Kennedy
Journal:  Sci Rep       Date:  2022-09-13       Impact factor: 4.996

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.